Polymun Scientific

Polymun operates a GMP-compliant pilot plant for the production of clinical grade material. Entirely new projects as well as missing elements of existing production processes can be custom designed via contract development.

The focus is on mammalian cell culture with a bioreactor capacity up to 1750 L. Batch, fed-batch, continuous and continuous perfused systems are used for suspension and adherent cell lines according to the process needs. The fermentation capacity per batch for microbial cell culture is up to 50 L. Polymun uses a standard purification scheme for antibody purification. This scheme is applied routinely, e.g. for our HIV antibodies which have been under clinical evaluation under IND of the FDA.

It is possible to manually fill bulk and end products in infusion bags, syringes and glass vials of various volumes in sufficient quantities for clinical studies in our GMP laboratories. Contract manufacturing includes the preparation of the CMC part for IMPD submission.

As small, independent and private company Polymun has no conflict of interests thus granting a high degree of flexibility and security for its clients including the possibility of technology transfer.

Is this your Organization? Request Access